Final Results of a Phase I/II Trial of the Combination Bendamustine and Rituximab With Temsirolimus (BeRT) in Relapsed Mantle Cell Lymphoma and Follicular Lymphoma
暂无分享,去创建一个
W. Klapper | M. Dreyling | G. Hess | M. Theobald | C. Ruckes | M. Witzens‐Harig | P. La Rosée | U. Keller | C. Medler | K. Hübel | J. Atta | K. Wagner | C. van Oordt | Karola Wagner | C. Lerchenmueller | Daniel Schoendube | Christoph Medler | Karola Wagner